MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. (RLAY)

|||

Balance Sheets Overview

Current Ratio
1826.79%
Quick Ratio
1826.79%
Cash Ratio
238.54%
Debt to Asset Ratio
8.01%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investments
    • Cash and cash equivalents
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
121,189
204,589
84,018
91,564
Investments
789,745
437,476
470,500
504,867
Prepaid expenses
8,735
11,835
17,787
23,839
Other current assets
8,413
4,562
5,974
3,744
Total current assets
928,082
658,462
578,279
624,014
Property and equipment, net
862
1,222
1,726
2,359
Operating lease assets
37,177
38,593
39,990
41,369
Restricted cash
1,336
1,336
1,336
2,258
Intangible asset
-
-
0
0
Total assets
967,457
699,613
621,331
670,000
Accounts payable
11,459
4,104
7,705
2,752
Accrued expenses
34,079
20,912
13,645
25,132
Operating lease liabilities
4,014
3,888
3,765
3,643
Other current liabilities
1,252
847
463
1,078
Total current liabilities
50,804
29,751
25,578
32,605
Operating lease liabilities, net of current portion
26,644
27,679
28,693
29,686
Total liabilities
77,448
57,430
54,271
62,291
Common stock, 0.001 par value 450,000,000 and 300,000,000 shares authorized as of june 30, 2026, and december 31, 2025, respectively 218,531,200 and 173,868,949 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
211
182
168
168
Additional paid-in capital
3,063,118
2,730,233
2,580,928
2,566,927
Accumulated other comprehensive (loss) gain
-1,553
-172
733
493
Accumulated deficit
-2,171,767
-2,088,060
-2,014,769
-1,959,879
Total stockholders' equity
890,009
642,183
567,060
607,709
Total liabilities and stockholders' equity
967,457
699,613
621,331
670,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$789,745K (45.49%↑ Y/Y)Cash and cashequivalents$121,189K (6.36%↑ Y/Y)Prepaid expenses$8,735K (-45.54%↓ Y/Y)Other current assets$8,413K (11.03%↑ Y/Y)Total current assets$928,082K (36.40%↑ Y/Y)Operating lease assets$37,177K (-13.00%↓ Y/Y)Restricted cash$1,336K (-40.83%↓ Y/Y)Property and equipment,net$862K (-75.09%↓ Y/Y)Total assets$967,457K (32.74%↑ Y/Y)Total liabilities andstockholders' equity$967,457K (32.74%↑ Y/Y)Total stockholders'equity$890,009K (33.70%↑ Y/Y)Total liabilities$77,448K (22.58%↑ Y/Y)Accumulated deficit-$2,171,767K (-15.17%↓ Y/Y)Accumulated othercomprehensive (loss) gain-$1,553K (-852.76%↓ Y/Y)Additional paid-in capital$3,063,118K (20.06%↑ Y/Y)Total currentliabilities$50,804K (56.20%↑ Y/Y)Operating leaseliabilities, net of current...$26,644K (-13.09%↓ Y/Y)Common stock, 0.001 parvalue 450,000,000 and...$211K (25.60%↑ Y/Y)Accrued expenses$34,079K (46.80%↑ Y/Y)Accounts payable$11,459K (121.39%↑ Y/Y)Operating leaseliabilities$4,014K (13.87%↑ Y/Y)Other currentliabilities$1,252K (105.58%↑ Y/Y)